Testing effectiveness (Phase 2)Study completedNCT01499420
What this trial is testing
A Single Ascending Dose Study Examining the Safety and Pharmacokinetic Profile of Reconstituted High Density Lipoprotein (CSL112) Administered to Patients
Who this might be right for
Stable Atherothrombotic Disease
CSL Limited 45